Companies / Edesa Biotech, Inc.
Edesa Biotech, Inc.
Nasdaq: EDSACIK 1540159MARKHAM
Financials · FY2021
Ownership
8.9M shares outstanding · as of May 13, 2026
Ownership
| Insiders | 14.15% | 1,258,385 |
| Institutions | 41.71% | 3,709,074 |
| Public float | 44.14% | 3,924,492 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 2
View all →| Insider | % of shares | Shares |
|---|---|---|
Pardeep Nijhawan Medicine Professional CorporationCEOChief Executive Officer · Director · 10% owner | 11.60% | 1,031,515 |
Brooks Michael JPresident | 2.55% | 226,870 |
Institutional holders 27
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.95M | 6.33% | |
| $976.3K | 7.73% | |
| $976.3K | 7.73% | |
| $976.3K | 7.73% | |
| $887.5K | 7.03% | |
| $403.0K | 0.87% | |
| $308.8K | 0.43% | |
| $223.5K | 0.31% | |
| $190.6K | 1.51% | |
| $82.9K | 0.18% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $66.7K | +30K +8.78% | 371,702 4.18% of shares | medium |
| Mar 4, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $42.6K | +10K +2.61% | 392,702 4.42% of shares | low |
| Mar 5, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $39.0K | +10K +2.55% | 402,702 4.53% of shares | low |
| Mar 3, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $36.3K | +10K +2.68% | 382,702 4.30% of shares | low |
| Feb 26, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $32.5K | +21K +3.46% | 615,797 6.93% of shares | low |
| Mar 10, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $6.6K | +1K +0.16% | 628,813 7.07% of shares | low |
| Mar 2, 2026 | Pardeep Nijhawan Medicine Professional Corporation CEO | Buy | Common Shares | $4.0K | +2K +0.32% | 627,813 7.06% of shares | low |
| Feb 26, 2026 | Brooks Michael J Executive | Buy | Common Shares | $3.1K | +2K +0.89% | 226,870 2.55% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Perceptive Advisors LLC | Passive13G | — |
| Nantahala Capital Management, LLC | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G | — |
| Integrated Core Strategies (US) LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EDSA | — | 27966L306 |